Leveraged Finance Fights Melanoma
Leveraged Finance Fights Melanoma (LFFM) was held on Wednesday May 24th from 6-9 p.m. at the Rockefeller Center. The event was chaired by Brendan Dillon of UBS; Lee Grinberg of Elliott Management; George Mueller of KKR; Jeff Rowbottom of PSP Investments; Cade Thompson of KKR and Trevor Watt of Hellman & Friedman.
Following the main event, attendees gathered at Connolly’s Irish Pub on West 45 Street between 6th and 7th Avenues. The venue, food and drink was graciously donated.
More about LFFM
Spotlighted in publications like Forbes, Bloomberg and The New York Times, the Leveraged Finance Fights Melanoma (LFFM) event has become the premier gathering of professionals from the leveraged finance, private equity, and investment communities who come together to fight melanoma, the deadliest form of skin cancer. Some of the most prominent names in the industry —Carl Icahn, Mike Milken, Leon Black, Henry Kravis and Howard Marks—have been featured.
|Leon Black, Carl Icahn, Gail Ichahn, and Debra Black
Click here to see photos from past LFFM events
The annual event raises critical funds for melanoma research and awareness on skin cancer prevention. Founded in 2011 by Jeffrey Rowbottom of PSP Investments and Brendan Dillon of UBS—both of whom combatted melanoma— the LFFM event has raised more than $8.6 million that goes directly to research.
Advances in melanoma research supported by MRA have changed the landscape dramatically for patients, with 11 of the 13 treatment options coming to market since the event’s kick-off. These advances have created a ripple effect across the field of oncology. Drugs first approved in melanoma are now being tested in more than 30 cancers.
Because prevention is key to lowering the risk of being diagnosed, LFFM attendees are encouraged to sign up for a skin check pledge, committing to have their skin examined by a dermatologist within 6 months. For each person taking the skin check pledge, L'Oréal Paris has committed $100 per sign up, up to $250,000 for 2017. L'Oréal Paris is a featured partner of the Melanoma Research Alliance, committed to supporting research. To date, L'Oréal Paris has promised to fund $1.5 million in grants.